טוען...
Loss of GM-CSF signalling in non-haematopoietic cells increases NSAID ileal injury
BACKGROUND: Administration of granulocyte-macrophage colony stimulating factor (GM-CSF) relieves symptoms in Crohn's disease (CD). It has been reported that reduced GM-CSF bioactivity is associated with more aggressive ileal behaviour and that GM-CSF-null mice exhibit ileal barrier dysfunction...
שמור ב:
| הוצא לאור ב: | Gut |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2010
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4296557/ https://ncbi.nlm.nih.gov/pubmed/20584783 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2009.203893 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|